Depression and anxiety among hemophilia patients enrolled in clinical trials: a multi-center cohort study

Zhen Peng1, Xiaoyu Zhu2, Chongwei Wang1

  • 1Drug Clinical Trial Institution, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.

Insights

Hemophilia patients in clinical trials experience significant depression and anxiety. Acquiring medical information and baseline scores on the PHQ-9 and GAD-7 predict these psychological conditions, necessitating early intervention.

Area of Science:

  • Hematology
  • Psychiatry
  • Clinical Trials

Background:

  • Hemophilia patients in clinical trials often face physical and psychological challenges.
  • Anxiety and depression prevalence and risk factors in this population remain understudied.

Purpose of the Study:

  • To assess the impact of depression and anxiety on hemophilia patients in clinical trials.
  • To identify risk factors associated with depression and anxiety in this cohort.

Main Methods:

  • A multi-center, cohort study involving 69 hemophilia patients from January to December 2022.
  • Baseline (T1) risk factor assessment and psychological symptom evaluation.
  • Follow-up evaluation at 3 months (T2) to measure depression and anxiety levels.

Main Results:

  • Moderate-to-severe depression increased from 18.75% at T1 to 43.75% at T2; anxiety increased from 7.81% to 25.00%.
  • Depression worsened in 35.94% and anxiety in 18.75% of patients.
  • Frequent acquisition of medical information (OR 11.378), baseline GAD-7 (OR 1.341), and PHQ-9 (OR 1.465) scores predicted depression and anxiety.

Conclusions:

  • Hemophilia patients in clinical trials exhibit significant levels of anxiety and depression.
  • Medical information acquisition frequency and baseline PHQ-9/GAD-7 scores are key risk factors.
  • Clinical trial participants require education and psychological evaluations for timely intervention.

Related Concept Videos

Generalized Anxiety Disorder01:30

Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
169
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
294
Anxiety: Overview01:18

Anxiety: Overview

Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
316
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
181
Stress and Mental Health01:30

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
189
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.1K